Journal of Hepatocellular Carcinoma (Sep 2021)

Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies

  • Huber TC,
  • Bochnakova T,
  • Koethe Y,
  • Park B,
  • Farsad K

Journal volume & issue
Vol. Volume 8
pp. 1181 – 1193

Abstract

Read online

Timothy C Huber, Teodora Bochnakova, Yilun Koethe, Brian Park, Khashayar Farsad Dotter Department of Interventional Radiology, Oregon Health and Science University, Portland, OR, USACorrespondence: Khashayar Farsad Email [email protected]: Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and clinical aspects of both existing and emerging percutaneous treatment options for HCC.Keywords: hepatocellular carcinoma, ablation, microwave, radiofrequency, electroporation, nanoparticles, cryoablation

Keywords